Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive Function

NCT00645580 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Fluvoxamine

Sponsor

Sha'ar Menashe Mental Health Center